Royal Society of Chemistry, Biomaterials Science, 10(7), p. 4022-4026, 2019
DOI: 10.1039/c9bm01145e
Full text: Unavailable
Since current subunit vaccines are limited by a short halflife in vivo and weak immune responses when used alone without adjuvants, there is an unmet need for combing carriers with complement activation signals to interrupt outbreaks in real-time.